Galectin-7 as a potential biomarker of Stevens-Johnson syndrome/toxic epidermal necrolysis: identification by targeted proteomics using causative drug-exposed peripheral blood cells

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE

ELSEVIER

1. Japan Agency for Medical Research and Development (AMED) [18ek0109317h0001]
2. KAKENHI [18H04047, 18K16020]
3. Grants-in-Aid for Scientific Research [18H04047, 18K16020] Funding Source: KAKEN